Warning letter
Carrington Laboratories, Inc: warning letter of Dec 5, 2005
FDA warning letter UCM075727 · Dallas District Office
Key facts
| Reference number | UCM075727 |
|---|---|
| Company | Carrington Laboratories, Inc |
| Subject | Insanitary Conditions/Adulterated/Misbranded |
| Issue date | Dec 5, 2005 |
| Posted date | Dec 5, 2005 |
| Issuing office | Dallas District Office |
| Product type | Unknown |
| Country | 3 |
| Inspection city | Irving |
| Inspection ZIP | 75038-4404 |
| Inspection start date | Aug 24, 2005 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: